Abstract | BACKGROUND: Mixed-valent diruthenium tetracarboxylate complexes were shown to have slight antineoplastic activity against P388 leukemia cell lines. However these complexes suffered from poor water-solubility, which may have detrimentally affected their activity. MATERIALS AND METHODS: Mixed-valent diruthenium tetracarboxylates of the type [Ru2(O2CR)4(L)2] (PF6) with L = imidazole, 1-methylimidazole and H2O when R = CH3, L = ethanol when R = Fc (ferrocenyl) or Fc-CH=CH- and of the type M3[Ru2(O2CR)4(H2O)2]4H2O, M = Na+ when R = m-C6H4SO3- and M = K+ when R = p-C6H4SO3-, were tested for cytotoxicity against HeLa and multidrug resistant CoLo 320DM human cancer cell lines. Cell survival was measured by means of the colorometric 3-(4,5dimethylthiazol-2-yl)-diphenyltetrazodium bromide assay. RESULTS: The mean drug concentration from 3 experiments causing 50% cell killing, ie, IC50 values, varied between 120 and 950 micromol dm(-3). CONCLUSION: The antineoplastic activity of the highly water-soluble m-sulpho derivative was the highest, while the poorly water-soluble imidazole derivatives did not exhibit any cytotoxic properties. The CoLo 320DM cancer cells were 5 times more prone to drug-induced cell death than the HeLa cells.
|
Authors | Constance E J Van Rensburg, Elke Kreft, Jannie C Swarts, Sean R Dalrymple, Denise M MacDonald, Michael W Cooke, Manuel A S Aquino |
Journal | Anticancer research
(Anticancer Res)
2002 Mar-Apr
Vol. 22
Issue 2A
Pg. 889-92
ISSN: 0250-7005 [Print] Greece |
PMID | 12014667
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Organometallic Compounds
- Ruthenium
|
Topics |
- Animals
- Antineoplastic Agents
(chemistry, toxicity)
- Drug Screening Assays, Antitumor
- HeLa Cells
(drug effects)
- Humans
- Leukemia P388
(drug therapy)
- Mice
- Organometallic Compounds
(chemistry, toxicity)
- Ruthenium
(chemistry, toxicity)
|